{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:51:29Z","timestamp":1791557489731,"version":"4.3.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Demand for O RhD-negative red cells continues to rise, while overall red cell transfusions have decreased, compounding inventory management challenges. We analyzed O RhD-negative red cell utilization in a large publicly available database.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data from 378,855 red cell transfusions were evaluated using the Recipient Epidemiology and Donor Evaluation Study-III (REDS-III). Utilization patterns, recipient demographics, and their correlation with the age of red cell units at transfusion were examined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The majority of O RhD-negative units were transfused to patients with blood groups other than O RhD-negative (54.5%). A larger percentage of O RhD-negative red cells were transfused after 35\u2009days of collection (41%), compared to other blood groups (18.7%). Patients over 50\u2009years, males, non-O RhD-negative and RhD-positive individuals had higher odds of receiving units stored more than 35\u2009days. Patients with higher hemoglobin concentrations were more likely to receive older blood units.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The analysis identified opportunities to improve the allocation of O RhD-negative red cell units, highlighting current inventory practices as suboptimal. The findings call for refined allocation strategies to improve the utilization of this limited resource. The implementation of real-time management approaches may balance the retention of such red cell units with the needs of patients who benefit from the use of RhD-negative blood.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-026-08704-y","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T09:36:04Z","timestamp":1785836164000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Improved allocation strategies for red cell units of blood group O and RhD-negative revealed by current suboptimal utilization"],"prefix":"10.1186","volume":"24","author":[{"given":"Abdullah","family":"Alswied","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1631-7198","authenticated-orcid":false,"given":"Willy Albert","family":"Flegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"issue":"4","key":"8704_CR1","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1213\/ANE.0000000000001496","volume":"123","author":"A Shander","year":"2016","unstructured":"Shander A, Bracey AW Jr, Goodnough LT, Gross I, Hassan NE, Ozawa S, et al. Patient blood management as standard of care. Anesth Analg. 2016;123(4):1051\u201353. https:\/\/doi.org\/10.1213\/ANE.0000000000001496.","journal-title":"Anesth Analg"},{"issue":"9","key":"8704_CR2","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1111\/trf.12802","volume":"54","author":"JL Callum","year":"2014","unstructured":"Callum JL, Waters JH, Shaz BH, Sloan SR, Murphy MF. The AABB recommendations for the choosing wisely campaign of the American board of internal medicine. Transfusion. 2014;54(9):2344\u201352. https:\/\/doi.org\/10.1111\/trf.12802.","journal-title":"Transfusion"},{"issue":"19","key":"8704_CR3","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1001\/jama.2023.12914","volume":"330","author":"JL Carson","year":"2023","unstructured":"Carson JL, Stanworth SJ, Guyatt G, Valentine S, Dennis J, Bakhtary S, et al. Red blood cell transfusion: 2023 AABB international guidelines. JAMA. 2023;330(19):1892\u2013902. https:\/\/doi.org\/10.1001\/jama.2023.12914.","journal-title":"JAMA"},{"issue":"19","key":"8704_CR4","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1001\/jama.2016.9185","volume":"316","author":"JL Carson","year":"2016","unstructured":"Carson JL, Guyatt G, Heddle NM, Grossman BJ, Cohn CS, Fung MK, et al. Clinical practice guidelines from the AABB: red blood cell transfusion thresholds and storage. Jama JAMA. 2016;316(19):2025\u201335. https:\/\/doi.org\/10.1001\/jama.2016.9185.","journal-title":"JAMA"},{"issue":"1","key":"8704_CR5","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1182\/hematology.2019000063","volume":"2019","author":"MF Murphy","year":"2019","unstructured":"Murphy MF, Palmer A. Patient blood management as the standard of care. Hematol Am Soc Hematol Educ Program 2019. 2019;2019(1):583\u201389. https:\/\/doi.org\/10.1182\/hematology.2019000063.","journal-title":"Hematol Am Soc Hematol Educ Program 2019"},{"issue":"2","key":"8704_CR6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.7326\/M18-3145","volume":"170","author":"A Shander","year":"2019","unstructured":"Shander A, Goodnough LT. From tolerating anemia to treating anemia. Ann Intern Med. 2019;170(2):125\u201326. https:\/\/doi.org\/10.7326\/M18-3145.","journal-title":"Ann Intern Med"},{"key":"8704_CR7","doi-asserted-by":"publisher","unstructured":"Free RJ, Sapiano MRP, Chavez Ortiz JL, Stewart P, Berger J, Basavaraju SV. Continued stabilization of blood collections and transfusions in the United States: findings from the 2021 national blood collection and utilization survey. Findings 2021 Natl Blood Collection Utilization Survey. Tranfus. 2023;63(S4):S8\u201318. https:\/\/doi.org\/10.1111\/trf.17360.","DOI":"10.1111\/trf.17360"},{"key":"8704_CR8","doi-asserted-by":"publisher","unstructured":"Jones JM, Sapiano MRP, Mowla S, Bota D, Berger JJ, Basavaraju SV. Has the trend of declining blood transfusions in the United States ended? Findings of the 2019 national blood collection and utilization survey. Findings 2019 Natl Blood Collection Utilization Survey. Tranfus. 2021;61(S2):S1\u201310. https:\/\/doi.org\/10.1111\/trf.16449.","DOI":"10.1111\/trf.16449"},{"issue":"6","key":"8704_CR9","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1111\/trf.14547","volume":"58","author":"NM Dunbar","year":"2018","unstructured":"Dunbar NM, Yazer MH. O\u2013 product transfusion, inventory management, and utilization during shortage: the OPTIMUS study. Transfusion. 2018;58(6):1348\u201355. https:\/\/doi.org\/10.1111\/trf.14547.","journal-title":"Transfusion"},{"key":"8704_CR10","doi-asserted-by":"publisher","unstructured":"Kracalik I, Sapiano MRP, Wild RC, Chavez Ortiz J, Stewart P, Berger JJ, et al. Supplemental findings of the 2021 national blood collection and utilization survey. Supplemental Findings 2021 Natl Blood Collection Utilization Survey. Tranfus. 2023;63(S4):S19\u201342. https:\/\/doi.org\/10.1111\/trf.17509.","DOI":"10.1111\/trf.17509"},{"issue":"5","key":"8704_CR11","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/j.1537-2995.2004.03338.x","volume":"44","author":"G Garratty","year":"2004","unstructured":"Garratty G, Glynn SA, McEntire R. ABO and Rh(D) phenotype frequencies of different racial\/ethnic groups in the United States. Transfusion. 2004;44(5):703\u201306. https:\/\/doi.org\/10.1111\/j.1537-2995.2004.03338.x.","journal-title":"Transfusion"},{"issue":"1","key":"8704_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejor.2011.05.026","volume":"217","author":"J Beli\u00ebn","year":"2012","unstructured":"Beli\u00ebn J, Forc\u00e9 H. Supply chain management of blood products: a literature review. Eur J Oper Res. 2012;217(1):1\u201316. https:\/\/doi.org\/10.1016\/j.ejor.2011.05.026.","journal-title":"Eur J Oper Res"},{"issue":"1","key":"8704_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/bjh.12747","volume":"165","author":"WA Flegel","year":"2014","unstructured":"Flegel WA, Natanson C, Klein HG. Does prolonged storage of red blood cells cause harm? Br J Haematol. 2014;165(1):3\u201316. https:\/\/doi.org\/10.1111\/bjh.12747.","journal-title":"Br J Haematol"},{"key":"8704_CR14","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.1111\/trf.15344","volume":"59","author":"C Atreya","year":"2019","unstructured":"Atreya C, Glynn S, Busch M, Kleinman S, Snyder E, Rutter S, et al. Proceedings of the Food and Drug Administration public workshop on pathogen reduction technologies for blood safety 2018. Transfusion. 2019: 3002\u201325, 59.","journal-title":"Transfusion"},{"issue":"12","key":"8704_CR15","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1111\/trf.12171","volume":"53","author":"WH Dzik","year":"2013","unstructured":"Dzik WH, Beckman N, Murphy MF, Delaney M, Flanagan P, Fung M, et al. Factors affecting red blood cell storage age at the time of transfusion. Transfusion. 2013;53(12):3110\u201319. https:\/\/doi.org\/10.1111\/trf.12171.","journal-title":"Transfusion"},{"issue":"11","key":"8704_CR16","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1111\/vox.13357","volume":"117","author":"M Ilmakunnas","year":"2022","unstructured":"Ilmakunnas M, Salmela K, Kivipuro T, Sareneva H, Sainio S. Use of O RhD-negative red blood cells: a nationwide, prospective audit. Vox Sang. 2022;117(11):1279\u201386. https:\/\/doi.org\/10.1111\/vox.13357.","journal-title":"Vox Sang"},{"issue":"3","key":"8704_CR17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1046\/j.1537-2995.1996.36396182136.x","volume":"36","author":"BH Newman","year":"1996","unstructured":"Newman BH, Shafer AW, Saeed SM. Patterns of use of group O, Rh-negative red cells in a large metropolitan area and an action plan to control utilization. Transfusion. 1996;36(3):209\u201312. https:\/\/doi.org\/10.1046\/j.1537-2995.1996.36396182136.x.","journal-title":"Transfusion"},{"issue":"5","key":"8704_CR18","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1111\/trf.14012","volume":"57","author":"R Hirani","year":"2017","unstructured":"Hirani R, Wong J, Diaz P, Mondy P, Hogan C, Dennington PM, et al. A national review of the clinical use of group O D\u2013 red blood cell units. Transfusion. 2017;57(5):1254\u201361. https:\/\/doi.org\/10.1111\/trf.14012.","journal-title":"Transfusion"},{"issue":"10","key":"8704_CR19","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1111\/trf.14255","volume":"57","author":"MP Zeller","year":"2017","unstructured":"Zeller MP, Barty R, Aandahl A, Apelseth TO, Callum J, Dunbar NM, et al. Collaborative BEfST. An international investigation into O red blood cell unit administration in hospitals: the GRoup O utilization patterns (GROUP) study. Transfusion. 2017;57(10):2329\u201337. https:\/\/doi.org\/10.1111\/trf.14255.","journal-title":"Transfusion"},{"issue":"2","key":"8704_CR20","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.tracli.2021.01.005","volume":"28","author":"M Liker","year":"2021","unstructured":"Liker M, Luka\u0107 IK, Burna\u0107 IL, Bojani\u0107 I, Raos M, \u0106epuli\u0107 BG. Utilisation patterns of group O red blood cell transfusion by ABO and D non-identical recipients in large academic hospital. Tranfus Clinique et Biologique. 2021;28(2):186\u201390. https:\/\/doi.org\/10.1016\/j.tracli.2021.01.005.","journal-title":"Tranfus Clinique et Biologique"},{"issue":"3","key":"8704_CR21","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/tme.12310","volume":"26","author":"N Beckman","year":"2016","unstructured":"Beckman N, Yazer M, Land K, Chesneau S, Caulfield J. Blood banks meet the paradox of Gabriel\u2019s Horn: what are the options to maintain supply as demand decreases? Transfus Med. 2016;26(3):170\u201376. https:\/\/doi.org\/10.1111\/tme.12310.","journal-title":"Transfus Med"},{"issue":"21","key":"8704_CR22","doi-asserted-by":"publisher","first-page":"5103","DOI":"10.1182\/blood.V124.21.5103.5103","volume":"124","author":"R Barty","year":"2014","unstructured":"Barty R, Liu Y, Pai M, Jaffer A, Eikelboom JW, Cook RJ, et al. Utilization of universal group O blood by non group O recipients. Blood. 2014;124(21):5103\u20135103. https:\/\/doi.org\/10.1182\/blood.V124.21.5103.5103.","journal-title":"Blood"},{"issue":"4","key":"8704_CR23","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/vox.12492","volume":"112","author":"R Barty","year":"2017","unstructured":"Barty R, Pai M, Liu Y, Arnold D, Cook R, Zeller M, et al. Group O RBCs: where is universal donor blood being used. Vox Sang. 2017;112(4):336\u201342. https:\/\/doi.org\/10.1111\/vox.12492.","journal-title":"Vox Sang"},{"issue":"8","key":"8704_CR24","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1111\/trf.13696","volume":"56","author":"MH Yazer","year":"2016","unstructured":"Yazer MH, Jackson B, Beckman N, Chesneau S, Bowler P, Delaney M, et al. Changes in blood center red blood cell distributions in the era of patient blood management: the trends for collection (TFC) study. Transfusion. 2016;56(8):1965\u201373. https:\/\/doi.org\/10.1111\/trf.13696.","journal-title":"Transfusion"},{"key":"8704_CR25","unstructured":"Murphy M, BenAvram D. Recommendations on the use of group O red blood cells. AABB Assoc Bull. 2019, 19\u201302."},{"issue":"2","key":"8704_CR26","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/tme.12102","volume":"24","author":"J Page","year":"2014","unstructured":"Page J, Jones A, Macrate E, Webb M, Birchall J. A survey of O RhD-negative red cells in the South West: stocks and distribution compared to use and wastage. Transfus Med. 2014;24(2):109\u201313. https:\/\/doi.org\/10.1111\/tme.12102.","journal-title":"Transfus Med"},{"issue":"3","key":"8704_CR27","doi-asserted-by":"publisher","first-page":"313","DOI":"10.18231\/j.jdpo.2020.060","volume":"5","author":"M Sanwalka","year":"2020","unstructured":"Sanwalka M, Sharma R. Utilization of blood and blood products in a tertiary care hospital- a descriptive cohort study 2020. IP J Diagnostic Pathol Oncol. 2020;5(3):313\u201317. https:\/\/doi.org\/10.18231\/j.jdpo.2020.060.","journal-title":"IP J Diagnostic Pathol Oncol"},{"issue":"1","key":"8704_CR28","doi-asserted-by":"publisher","first-page":"54","DOI":"10.4103\/GJTM.GJTM_70_19","volume":"5","author":"T Yangdon","year":"2020","unstructured":"Yangdon T, Getshen M, Tashi L. A retrospective analysis of blood requisition versus utilization practices at National blood Bank, Jigme Dorji Wangchuck National referral hospital, Thimphu, Bhutan. Glob J Transfus Med. 2020;5(1):54\u201357. https:\/\/doi.org\/10.4103\/GJTM.GJTM_70_19.","journal-title":"Glob J Transfus Med"},{"key":"8704_CR29","unstructured":"The national heart L, and blood institute. Recipient epidemiology and donor evaluation study III (REDS III) vein to vein databases. 2021"},{"issue":"3pt2","key":"8704_CR30","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1111\/trf.12468","volume":"54","author":"S Kleinman","year":"2014","unstructured":"Kleinman S, Busch MP, Murphy EL, Shan H, Ness P, Glynn SA. The national heart, lung, and Blood institute recipient epidemiology and donor evaluation study (REDS-III): a research program striving to improve blood donor and transfusion recipient outcomes. Transfusion. 2014;54(3pt2):942\u201355. https:\/\/doi.org\/10.1111\/trf.12468.","journal-title":"Transfusion"},{"issue":"4","key":"8704_CR31","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/trf.15713","volume":"60","author":"MS Virk","year":"2020","unstructured":"Virk MS, Lancaster D, Quach T, Lim A, Shu E, Belanger G, et al. Optimizing O-negative RBC utilization using a data-driven approach. Transfusion. 2020;60(4):739\u201346. https:\/\/doi.org\/10.1111\/trf.15713.","journal-title":"Transfusion"},{"issue":"5","key":"8704_CR32","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1111\/trf.15788","volume":"60","author":"WA Flegel","year":"2020","unstructured":"Flegel WA, Wagner FF, \u00d3 Donghaile DP. Anti-D immunization rates may exceed 50% in many clinically relevant settings, despite varying widely among patient cohorts. Transfusion. 2020;60(5):1109\u201310. https:\/\/doi.org\/10.1111\/trf.15788.","journal-title":"Transfusion"},{"issue":"1","key":"8704_CR33","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1080\/16078454.2021.1905395","volume":"26","author":"M Yazer","year":"2021","unstructured":"Yazer M, Triulzi D, Sperry J, Corcos A, Seheult J. Rate of RhD-alloimmunization after the transfusion of RhD-positive red blood cell containing products among injured patients of childbearing age: single center experience and narrative literature review. Hematology. 2021;26(1):321\u201327. https:\/\/doi.org\/10.1080\/16078454.2021.1905395.","journal-title":"Hematology"},{"key":"8704_CR34","doi-asserted-by":"publisher","unstructured":"Yazer MH, Triulzi DJ, Sperry JL, Seheult JN. Rate of RhD-alloimmunization after the transfusion of multiple RhD-positive primary red blood cell-containing products. Transfusion. 2021;61(S1):S150\u20138. https:\/\/doi.org\/10.1111\/trf.16495.","DOI":"10.1111\/trf.16495"},{"key":"8704_CR35","doi-asserted-by":"publisher","unstructured":"Seheult JN, Callum J, Delaney M, Drake R, Dunbar NM, Harm SK, et al. Rate of D-alloimmunization in trauma does not depend on the number of RhD-positive units transfused: the BEST collaborative study. Transfusion. 2022;62(S1):S185\u201392. https:\/\/doi.org\/10.1111\/trf.16952.","DOI":"10.1111\/trf.16952"},{"issue":"02","key":"8704_CR36","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1055\/a-2138-6295","volume":"14","author":"S Flommersfeld","year":"2024","unstructured":"Flommersfeld S, Ertl B. Strategien zur Versorgung von RhD-negativen Patienten mit RhD-positiven Erythrozytenkonzentraten. Transfusionsmedizin. 2024;14(02):89\u201394. https:\/\/doi.org\/10.1055\/a-2138-6295.","journal-title":"Transfusionsmedizin"},{"issue":"5","key":"8704_CR37","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1111\/trf.18249","volume":"65","author":"LD Ekstrom","year":"2025","unstructured":"Ekstrom LD, Clements M, Roubinian N, Zhao J, Dahlen T, Busch MP, et al. An agnostic study of donor and component factors associated with transfusion-related changes in laboratory markers. Transfusion. 2025;65(5):886\u201396. https:\/\/doi.org\/10.1111\/trf.18249.","journal-title":"Transfusion"},{"key":"8704_CR38","unstructured":"AABB. Weekly blood supply report [monograph on the internet]. Online; 2017-2024. Available from: https:\/\/www.aabb.org\/for-donors-patients\/weekly-blood-supply-report."},{"issue":"2","key":"8704_CR39","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/bjhp.12551","volume":"27","author":"J Ou-Yang","year":"2022","unstructured":"Ou-Yang J, Huang X-Y, Fu Y-S, Dai L, Zhong H-B, Jiang J, et al. Effects of message framing on recruiting Rh-D-negative blood donors in an emergency situation: two randomized trials. Br J Health Psychol. 2022;27(2):406\u201333. https:\/\/doi.org\/10.1111\/bjhp.12551.","journal-title":"Br J Health Psychol"},{"issue":"7","key":"8704_CR40","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1111\/j.1537-2995.2006.00856.x","volume":"46","author":"P Reich","year":"2006","unstructured":"Reich P, Roberts P, Laabs N, Chinn A, McEvoy P, Hirschler N, et al. A randomized trial of blood donor recruitment strategies. Transfusion. 2006;46(7):1090\u201396. https:\/\/doi.org\/10.1111\/j.1537-2995.2006.00856.x.","journal-title":"Transfusion"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08704-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08704-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08704-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:16:36Z","timestamp":1791555396000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08704-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8704"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08704-y","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"assertion":[{"value":"6 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This research was supported in part by the Intramural Research Program of the National Institutes of Health (NIH). The contributions of the NIH authors are considered Works of the United States Government. The findings and conclusions presented in this paper are those of the authors and do not necessarily reflect the views of the NIH or the U.S. Department of Health and Human Services.","order":1,"name":"Ethics","label":"Disclaimer","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable for this study. All underlying data are part of the REDS-III database, for which Institutional Review Board approval had been obtained during the REDS-III database creation, and the data complied with the National Heart, Lung, and Blood Institute data sharing policy.","order":2,"name":"Ethics","label":"Ethics and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1276"}}